242 related articles for article (PubMed ID: 32212297)
61. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).
Wong CM; Hawkins NM; Jhund PS; MacDonald MR; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Petrie MC; McMurray JJ
J Am Coll Cardiol; 2013 Nov; 62(20):1845-54. PubMed ID: 23850914
[TBL] [Abstract][Full Text] [Related]
62. Characteristics and outcomes of heart failure-related hospitalization in adults with congenital heart disease.
Moussa NB; Karsenty C; Pontnau F; Malekzadeh-Milani S; Boudjemline Y; Legendre A; Bonnet D; Iserin L; Ladouceur M
Arch Cardiovasc Dis; 2017 May; 110(5):283-291. PubMed ID: 28314706
[TBL] [Abstract][Full Text] [Related]
63. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
[No Abstract] [Full Text] [Related]
64. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.
Streng KW; Nauta JF; Hillege HL; Anker SD; Cleland JG; Dickstein K; Filippatos G; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Zannad F; Damman K; van der Meer P; Voors AA
Int J Cardiol; 2018 Nov; 271():132-139. PubMed ID: 30482453
[TBL] [Abstract][Full Text] [Related]
65. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
Mentz RJ; Fiuzat M; Wojdyla DM; Chiswell K; Gheorghiade M; Fonarow GC; O'Connor CM
Eur J Heart Fail; 2012 Apr; 14(4):395-403. PubMed ID: 22302663
[TBL] [Abstract][Full Text] [Related]
66. Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure.
Lindberg F; Lund LH; Benson L; Schrage B; Edner M; Dahlström U; Linde C; Rosano G; Savarese G
ESC Heart Fail; 2022 Apr; 9(2):822-833. PubMed ID: 35170237
[TBL] [Abstract][Full Text] [Related]
67. Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization.
Terzano C; Colamesta V; Unim B; Romani S; Meneghini A; Volpe G; La Torre G
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3680-3689. PubMed ID: 28925473
[TBL] [Abstract][Full Text] [Related]
68. The effects of preexisting medical comorbidities on mortality and length of hospital stay in acute burn injury: evidence from a national sample of 31,338 adult patients.
Thombs BD; Singh VA; Halonen J; Diallo A; Milner SM
Ann Surg; 2007 Apr; 245(4):629-34. PubMed ID: 17414613
[TBL] [Abstract][Full Text] [Related]
69. Multimorbidity, guideline-directed medical therapies, and associated outcomes among hospitalized heart failure patients.
Takeuchi S; Kohno T; Goda A; Shiraishi Y; Kawana M; Saji M; Nagatomo Y; Nishihata Y; Takei M; Nakano S; Soejima K; Kohsaka S; Yoshikawa T;
ESC Heart Fail; 2022 Aug; 9(4):2500-2510. PubMed ID: 35561100
[TBL] [Abstract][Full Text] [Related]
70. Resource use in the last 6 months of life among patients with heart failure in Canada.
Kaul P; McAlister FA; Ezekowitz JA; Bakal JA; Curtis LH; Quan H; Knudtson ML; Armstrong PW
Arch Intern Med; 2011 Feb; 171(3):211-7. PubMed ID: 20937918
[TBL] [Abstract][Full Text] [Related]
71. Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.
Ergatoudes C; Schaufelberger M; Andersson B; Pivodic A; Dahlström U; Fu M
Clin Res Cardiol; 2019 Sep; 108(9):1025-1033. PubMed ID: 30788622
[TBL] [Abstract][Full Text] [Related]
72. Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
Yang M; Kondo T; Adamson C; Butt JH; Abraham WT; Desai AS; Jering KS; Køber L; Kosiborod MN; Packer M; Rouleau JL; Solomon SD; Vaduganathan M; Zile MR; Jhund PS; McMurray JJV
Eur J Heart Fail; 2023 Sep; 25(9):1606-1618. PubMed ID: 37401511
[TBL] [Abstract][Full Text] [Related]
73. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
[TBL] [Abstract][Full Text] [Related]
74. Relation of dyspnea severity on admission for acute heart failure with outcomes and costs.
Mentz RJ; Mi X; Sharma PP; Qualls LG; DeVore AD; Johnson KW; Fonarow GC; Curtis LH; Hernandez AF
Am J Cardiol; 2015 Jan; 115(1):75-81. PubMed ID: 25456875
[TBL] [Abstract][Full Text] [Related]
75. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.
Borow KM; Yaroshinsky A; Greenberg B; Perin EC
Circ Res; 2019 Jul; 125(3):265-281. PubMed ID: 31318648
[TBL] [Abstract][Full Text] [Related]
76. Relation of Concomitant Heart Failure to Outcomes in Patients Hospitalized With Influenza.
Panhwar MS; Kalra A; Gupta T; Kolte D; Khera S; Bhatt D; Ginwalla M
Am J Cardiol; 2019 May; 123(9):1478-1480. PubMed ID: 30819433
[TBL] [Abstract][Full Text] [Related]
77. Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study.
Beattie JM; Khatib R; Phillips CJ; Williams SG
Open Heart; 2020; 7(1):e001153. PubMed ID: 32201585
[TBL] [Abstract][Full Text] [Related]
78. The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial.
Mentz RJ; Schmidt PH; Kwasny MJ; Ambrosy AP; O'Connor CM; Konstam MA; Zannad F; Maggioni AP; Swedberg K; Gheorghiade M
J Card Fail; 2012 Jul; 18(7):515-23. PubMed ID: 22748484
[TBL] [Abstract][Full Text] [Related]
79. Impact of diabetes and sex in heart failure with reduced ejection fraction patients from the ASIAN-HF registry.
Chandramouli C; Teng TK; Tay WT; Yap J; MacDonald MR; Tromp J; Yan L; Siswanto B; Reyes EB; Ngarmukos T; Yu CM; Hung CL; Anand I; Richards AM; Ling LH; Regensteiner JG; Lam CSP;
Eur J Heart Fail; 2019 Mar; 21(3):297-307. PubMed ID: 30548089
[TBL] [Abstract][Full Text] [Related]
80. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
Chandra A; Vaduganathan M; Lewis EF; Claggett BL; Rizkala AR; Wang W; Lefkowitz MP; Shi VC; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV; Solomon SD;
JACC Heart Fail; 2019 Oct; 7(10):862-874. PubMed ID: 31302043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
